ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...
Zevtera is supplied as a single-dose vial containing 667 mg of ceftobiprole medocaril sodium as a lyophilized powder for reconstitution. Zevtera ® (ceftobiprole medocaril sodium for injection) is now ...
Fifteen years after Basilea's antibiotic ceftobiprole sustained a rejection from the FDA, the company has finally won over the U.S. regulator and done so in triplicate. The FDA has approved Basilea’s ...
Zevtera is a cephalosporin antibacterial with in vitro activity against gram-positive and gram-negative bacteria, including methicillin-resistant and susceptible Staphylococcus aureus. The Food and ...